Author

André St. Schrattenholz

Observed names: A Schrattenholz, A. SCHRATTENHOLZ, A. Schrattenholz, Andre SCHRATTENHOLZ, Andre Schrattenholz, André Schrattenholz, André S. SCHRATTENHOLZ, André Schrattenholz, André Schrattenholz

Observed institutions: Goethe University Frankfurt, University of Minnesota, Janssen (Belgium), Universität Ulm, Johannes Gutenberg University Mainz, Chinese Academy of Sciences, German Federal Institute for Risk Assessment (BfR), Technische Universität Darmstadt, University Medical Center of the Johannes Gutenberg University Mainz, Universitätsklinikum Tübingen, Shanghai Institutes for Biological Sciences, Center for Excellence in Molecular Cell Science, ProteoSys (Germany), University Hospital Ulm, University of Tübingen, Ludwig-Maximilians-Universität München

OpenAlex ID: A5036602289

Properties of Neuronal Nicotinic Acetylcholine Receptors: Pharmacological Characterization and Modulation of Synaptic Function,

1997 · Edson X. Albuquerque, Manickavasagom Alkondon, et al. · Journal of Pharmacology and Experimental Therapeutics · 437

Autocatalytic cleavage of Clostridium difficile toxin B

2007 · Jessica Reineke, Stefan Tenzer, et al. · Nature · 251

Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands.

1996 · A Schrattenholz, E F Pereira, et al. · Molecular Pharmacology · 226

The dynamics of the LPS triggered inflammatory response of murine microglia under different culture and in vivo conditions

2006 · Søren Lund, Kenneth Vielsted Christensen, et al. · Journal of Neuroimmunology · 217

Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer’s disease

2000 · Alfred Maelicke, Andre Schrattenholz, et al. · Behavioural Brain Research · 125

Identification and functional characterization of a new agonist site on nicotinic acetylcholine receptors of cultured hippocampal neurons.

1993 · E F Pereira, S Reinhardt-Maelicke, et al. · Journal of Pharmacology and Experimental Therapeutics · 125

Physostigmine, galanthamine and codeine act as ‘noncompetitive nicotinic receptor agonists’ on clonal rat pheochromocytoma cells

1995 · Alexander Storch, André Schrattenholz, et al. · European Journal of Pharmacology Molecular Pharmacology · 118

The nonerythropoietic asialoerythropoietin protects against neonatal hypoxia‐ischemia as potently as erythropoietin

2004 · Xiaoyang Wang, Changlian Zhu, et al. · Journal of Neurochemistry · 117

PDF

Putative adverse outcome pathways relevant to neurotoxicity

2015 · Anna Bal-Price, Kevin M. Crofton, et al. · Critical Reviews in Toxicology · 113

Expression and Prognostic Relevance of Annexin A3 in Prostate Cancer

2008 · Jens Köllermann, Thorsten Schlomm, et al. · European Urology · 110

The inflammatory transcriptome of reactive murine astrocytes and implications for their innate immune function

2006 · Jeppe Falsig, Peter Pörzgen, et al. · Journal of Neurochemistry · 109

PDF

Annexin A3 in Urine: A Highly Specific Noninvasive Marker for Prostate Cancer Early Detection

2008 · Martin Schostak, Gerhard P. Schwall, et al. · The Journal of Urology · 104

Nonenzymatic posttranslational protein modifications in ageing

2008 · Vukić Šoškić, Karlfried Groebe, et al. · Experimental Gerontology · 102

Differential proteomic profiling of mitochondria from Podospora anserina, rat and human reveals distinct patterns of age-related oxidative changes

2007 · Karlfried Groebe, Frank Krause, et al. · Experimental Gerontology · 88

Systemic administration of neuregulin‐1β1 protects dopaminergic neurons in a mouse model of Parkinson’s disease

2011 · Thomas Carlsson, Friederike R. Schindler, et al. · Journal of Neurochemistry · 80

Photoaffinity labeling of Torpedo acetylcholine receptor by physostigmine

1993 · Andre SCHRATTENHOLZ, Jasminka GODOVAC‐ZIMMERMANN, et al. · European Journal of Biochemistry · 80

PDF

The biological and ethical basis of the use of human embryonic stem cells for in vitro test systems or cell therapy

2008 · Marcel Leist, Susanne Bremer, et al. · ALTEX · 74

PDF

BACE-1 is expressed in the blood–brain barrier endothelium and is upregulated in a murine model of Alzheimer’s disease

2015 · Kavi Devraj, Slobodan Poznanovic, et al. · Journal of Cerebral Blood Flow & Metabolism · 70

Neuronal Nicotinic Receptors in the Locust Locusta migratoria

1998 · Bernhard Hermsen, Eva Stetzer, et al. · Journal of Biological Chemistry · 67

PDF

Breast cancer proteomics by laser capture microdissection, sample pooling, 54‐cm IPG IEF, and differential iodine radioisotope detection

2006 · Hans Neubauer, Susan E. Clare, et al. · Electrophoresis · 66

Comparative Profiling of the Mammalian Mitochondrial Proteome: Multiple Aconitase-2 Isoforms Including N -formylkynurenine Modifications as Part of a Protein Biomarker Signature for Reactive Oxidative Species

2006 · Christian Hunzinger, Wojciech Wozny, et al. · Journal of Proteome Research · 66

Minireview: Nicotinic Acetylcholine Receptors on Hippocampal Neurons: Distribution on the Neuronal Surface and Modulation of Receptor Activity

1997 · E. X. Albuquerque, E. F. R. Pereira, et al. · Journal of Receptors and Signal Transduction · 66

What Does Systems Biology Mean for Drug Development?

2008 · Andre Schrattenholz, Vukic Soskic · Current Medicinal Chemistry · 62

Global proteomic approach unmasks involvement of keratins 8 and 18 in the delivery of cystic fibrosis transmembrane conductance regulator (CFTR)/ΔF508‐CFTR to the plasma membrane

2004 · Noélie Davezac, Danielle Tondelier, et al. · PROTEOMICS · 62

Protein Expression Profiling in Esophageal Adenocarcinoma Patients Indicates Association of Heat-Shock Protein 27 Expression and Chemotherapy Response

2008 · Rupert Langer, Katja Ott, et al. · Clinical Cancer Research · 59

Works count: 104

Citation count: 4,168

H-index: 36

I10-index: 64